EQS-News: Mutares SE & Co. KGaA: Portfolio company Alcura France has received an irrevocable offer for the acquisition of its care services activity

Mutares SE & Co. KGaA: Portfolio company Alcura France has received an irrevocable offer for the acquisition of its care services activity

Munich, April 1, 2025 – Alcura France, a 100% subsidiary of Mutares SE & Co. KGaA (ISIN: DE000A2NB650), has received an irrevocable offer for the acquisition of its home healthcare services activity – referred to as PSAD (Prestations de Santé à Domicile) – from Santé Cie Group, a leading European player of homecare and ambulatory care. The targeted activity generated ca. EUR 17 million in revenues in France in 2024.

The closing of the transaction remains subject to customary conditions including the consultation of the relevant works councils.

Johannes Laumann, CIO of Mutares, comments: “Alcura France will continue developing its core business, notably its MAD (maintien à domicile), organically and through potential M&A activities. Alcura France will maintain a comprehensive service offering for its pharmacist customers while outsourcing non-core activities to prioritize shareholder returns.”

Company profile of Mutares SE & Co. KGaA

Mutares SE & Co. KGaA, Munich (www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process. For the fiscal year 2024, consolidated revenues of EUR 5.7 billion to EUR 6.3 billion are expected. Based on this, consolidated revenues are to be expanded to approx. EUR 7 billion by 2025 and EUR 10 billion by 2028. As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding. On this basis, the Holding Company is expected to generate a net income of EUR 108 million to EUR 132 million for the fiscal year 2024, EUR 125 million to EUR 150 million for the fiscal year 2025 and EUR 200 million for the fiscal year 2028. The Management Board and Supervisory Board together hold more than one-third of all Mutares shares with voting rights. The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650) and have been part of the selection index SDAX since December 2023

For more information, please contact:

Mutares SE & Co. KGaA
Investor Relations
Phone: +49 89 9292 7760
E-mail: ir@mutares.de
www.mutares.com

Press Contact in Germany
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone: +49 89 125 09 0333
E-mail: sh@crossalliance.de
www.crossalliance.de

Press Contact in France
CLAI
Matthieu Meunier
Phone: +33 06 26 59 49 05
E-mail: matthieu.meunier@clai2.com

Press Contact in UK
14:46 Consulting
Tom Sutton
Phone: +44 7796 474940
E-mail: tsutton@1446.co.uk